Rassi A Jr, Rassi A, Marin-Neto JA (2010) Chagas disease. Lancet 375: 1388–1402. doi: 10.1016/S0140-6736(10)60061-X
[2]
Rassi A Jr, Rassi AG, Rassi SG, Rassi L Jr, Rassi A (1995) [Ventricular arrhythmia in Chagas disease. Diagnostic, prognostic, and therapeutic features]. (In Portuguese). Arq Bras Cardiol 65: 377–387.
[3]
Samuel J, Oliveira M, Correa De Araujo RR, Navarro MA, Muccillo G (1983) Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol 52: 147–151. doi: 10.1016/0002-9149(83)90085-1
[4]
Rassi A Jr, Rassi SG, Rassi A (2001) Sudden death in Chagas' disease. Arq Bras Cardiol 76: 75–96. doi: 10.1590/S0066-782X2001000100008
[5]
Rassi A Jr, Rassi A, Little WC (2000) Chagas' heart disease. Clin Cardiol 23: 883–889. doi: 10.1002/clc.4960231205
[6]
Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, et al. (2007) Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA 298: 2171–2181. doi: 10.1001/jama.298.18.2171
[7]
Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, et al. (2006) Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 355: 799–808. doi: 10.1056/NEJMoa053241
[8]
Rassi A Jr, Rassi A, Rassi SG (2007) Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 115: 1101–1108. doi: 10.1161/CIRCULATIONAHA.106.627265
[9]
Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, et al. (2008) Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J 156: 37–43. doi: 10.1016/j.ahj.2008.04.001
[10]
Garguichevich JJ, Ramos JL, Gambarte A, Gentile A, Hauad S, et al. (1995) Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). Am Heart J 130: 494–500. doi: 10.1016/0002-8703(95)90357-7
[11]
Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, et al. (1994) Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 344: 493–498. doi: 10.1016/S0140-6736(94)91895-3
[12]
Chiale PA, Halpern MS, Nau GJ, Tambussi AM, Przybylski J, et al. (1984) Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis. Am Heart J 107: 656–665. doi: 10.1016/0002-8703(84)90311-9
[13]
Pazin-Filho A, Romano MM, Almeida-Filho OC, Furuta MS, Viviani LF, et al. (2006) Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications. Braz J Med Biol Res 39: 483–487. doi: /S0100-879X2006000400008
